Factor VIIIc inhibitors: an automated assay

Area of Science:

• Hematology
• Clinical Chemistry
• Immunology

Background:

• Factor VIIIc inhibitors are antibodies that neutralize factor VIII activity, complicating hemophilia treatment.
• Accurate measurement of these inhibitors is crucial for effective patient management and therapeutic strategies.
• Existing assays may have limitations in terms of safety, scope, or kinetic analysis.

Purpose of the Study:

• To describe a novel semi-automated assay for the detection and quantification of factor VIIIc inhibitors.
• To evaluate the assay's suitability for clinical laboratory settings, including handling of infectious samples.
• To assess the assay's capability for measuring both human and porcine inhibitors and for kinetic studies.

Main Methods:

• Development and validation of a semi-automated assay platform.
• Testing with samples containing known human and porcine factor VIIIc inhibitors.
• Inclusion of safety features for processing samples with infectious risks.
• Application of the assay for kinetic analysis of inhibitor-factor VIIIc interactions.

Main Results:

• The described assay is easy to perform and semi-automated, streamlining workflow.
• The assay is suitable for processing samples with a potential infectious risk, enhancing laboratory safety.
• It accurately measures both human and porcine factor VIIIc inhibitors.
• The assay's utility for kinetic studies of factor VIIIc inhibitors was demonstrated.

Conclusions:

• A practical and safe semi-automated assay for factor VIIIc inhibitors has been developed.
• This assay expands measurement capabilities to include human and porcine inhibitors.
• The method supports kinetic investigations, offering valuable insights into inhibitor mechanisms.